Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 15.245% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a. CC(=O)c1sc(NC(=O)COc2ccc(C(C)C)c(C)c2)nc1C
b. COc1ccc(Cl)cc1C(=O)Nc1nc(C)cc(C)n1
c. CN/C(=C\[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1
d. CCOc1ccc(CNC(=O)c2ccc3nc(N4CCOCC4)sc3c2)cc1
e. CCC(C)n1c(=O)c(C(=O)Nc2ccccc2S(N)(=O)=O)c(O)c2ccccc21
Answer: b. COc1ccc(Cl)cc1C(=O)Nc1nc(C)cc(C)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(Cl)cc1C(=O)Nc1nc(C)cc(C)n1
COc1ccc(Cl)cc1C(=O)Nc1nc(C)cc(C)n1
5-chloro-N-(4,6-dimethylpyrimidin-2-yl)-2-methoxybenzamide